Rie Ikeda
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan.
Journal: Advances in therapy
Published: September 02, 2024
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study.
Journal: Expert opinion on drug safety
Published: November 27, 2019
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 13, 2019
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 28, 2019
Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.
Journal: International journal of clinical oncology
Published: June 27, 2019
Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.
Journal: International journal of clinical oncology
Published: November 20, 2018
Preferential prescribing of linagliptin in type 2 diabetes patients in an expanded post-marketing surveillance study in Japan.
Journal: Journal of diabetes investigation
Published: September 06, 2018
Effects of glucocorticoid on postnatal development of rat sublingual glands.
Journal: Okajimas folia anatomica Japonica
Published: October 11, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026